News & Studies

Highlights from our latest work and achievements

View New EU clinical trial regulation

New EU clinical trial regulation

Article by Yvanne Enever and Dr Gita Patel
Monday, January 31st, 2022

The new EU clinical trial regulation (CTR) is set to revolutionise clinical trial processes across Europe impacting all European Member states and organisations wanting to run clinical trials across these regions. How can organisations prepare for the change and set themselves up successfully with a new CTR programme?

View Yvanne Enever, Founder/CEO reflects on 2021

Yvanne Enever, Founder/CEO reflects on 2021

Tuesday, January 4th, 2022

We are pleased to say that 2021 has seen PHARMExcel busier than ever. From delivering the Worlds’ first Booster Vaccine clinical trial leading to the shaping of UK Government policy, to welcoming new, key staff appointments and undertaking several charity events for Macmillan Cancer Support, Team PHARMExcel showed dedication to the cause. As we complete…

View PHARMExcel delighted to be the selected U.K. CRO delivering this pivotal clinical trial alongside colleagues at University Southampton, Cambridge and DIOSynVax.

PHARMExcel delighted to be the selected U.K. CRO delivering this pivotal clinical trial alongside colleagues at University Southampton, Cambridge and DIOSynVax.

Friday, December 17th, 2021

View PHARMExcel are pleased to announce the publication of the safety and immunogenicity data from the UK’s Covboost trial.

PHARMExcel are pleased to announce the publication of the safety and immunogenicity data from the UK’s Covboost trial.

Monday, December 6th, 2021

View Covid booster jabs will begin to be offered across the UK from next week based on JCVI decisions following COVBoost clinical trial data.

Covid booster jabs will begin to be offered across the UK from next week based on JCVI decisions following COVBoost clinical trial data.

Wednesday, September 15th, 2021

View PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions

PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions

Thursday, September 9th, 2021

View PHARMExcel supports recruitment of the first patient into INmuneBio’s pivotal MDS study showing promising results

PHARMExcel supports recruitment of the first patient into INmuneBio’s pivotal MDS study showing promising results

Wednesday, August 25th, 2021

View Initial covboost study data ready for analysis..

Initial covboost study data ready for analysis..

Tuesday, August 3rd, 2021

View PHARMExcel running MDS trial that sees first patient treated

PHARMExcel running MDS trial that sees first patient treated

Monday, July 12th, 2021

© Copyright 2025 PHARMExcel | Website by Union 10 Design